CPhi Worldwide
-
CDMOs to Benefit From Rising BTDs, Orphan Drugs and Fast Track Status
11.14.19
The arrival of patient-centric CDMO’s predicted by CPhI Annual Report.
-
Stevanato, Duoject Enter Auto-injector Collaboration
11.13.19
Partnership to promote and manufacture the emergency-use ‘Maverick’ auto-injector.
-
Thermo Fisher Bolsters China Presence
11.13.19
Opens customer solution center in Shanghai to support pharmaceutical and biopharmaceutical laboratories.
-
C2 Pharma Expands API Portfolio
11.13.19
Adds Digoxin micronized grade, Homatropine Hydrobromide and multiple products under tech transfer and development.
-
CPhI’s 16th Pharma Awards Winners
11.13.19
Dr. Ge Li wins ‘CEO of the Year’ and John Chiminski a ‘Lifetime Achievement’ award.
-
MilliporeSigma Licenses CRISPR Technology to Evotec
11.12.19
Will leverage CRISPR Portfolio to develop precisely engineered assays for potential drug candidates during the drug development cycle
-
West and SCHOTT Enter Packaging Partnership
11.11.19
To combine the SCHOTT iQ Platform with West's Ready Pack System.
-
IDT Biologika, NIH Mfg. Contract Updated
11.11.19
Awarded new task order in the scope of 10-year NIH contract to manufacture vaccines and biologics for infectious diseases.
-
Parsolex Selects Bosch Packaging Technology for New cGMP Facility
11.08.19
New Bosch Packaging machines will contribute to a range of clinical supply manufacturing programs.
-
Lonza Selects Cryoport as Preferred Partner
11.08.19
Will work to remove the supply chain hurdles faced by developers of Cell & Gene Therapies
-
Recipharm Invests in Nichepharm Lifesciences
11.07.19
Partnership aims to create production capacity in India for a range of sterile dosage forms
-
Aptar CSP Launches Xcelerate Development Services
11.06.19
Comprehensive service aims to fast-track active packaging solutions.
-
Shortfalls in Advanced Therapy Production & Growth in China Bio Capacity
11.05.19
CPhI Annual Report says a shortage of qualified personnel may be a drag factor in cell and gene therapies.
-
Barentz Acquires Majority Share in IMCoPharma
11.05.19
IMCoPharma is a leader in the pharmaceutical ingredients market in the CIS region and Ukraine.
-
Catalent Biologics Launches GPExR Boost Cell Line Expression Technology
11.05.19
Designed to improve titers and cell-specific productivity.
-
Samsung Biologics and Ichnos Sciences Ink Mfg. Deal
11.05.19
Samsung to manufacture drug substance for ISB 830 Phase 3 clinical trials and for potential future global commercial supply upon regulatory approval.
-
Recipharm Divests Bioanalysis Biz
11.04.19
Expands existing partnership with CTC Clinical Trial Consultants AB.
-
Raybow Expands CDMO Business to U.S. with Acquisition of PharmAgra Labs
11.04.19
Planning an expansion project at the PharmAgra site, adding additional capacity and personnel in the Brevard, NC area.
-
Europe to Surpass U.S. Biologic Manufacturing Capacity by 2023
11.04.19
CPhI Annual Report says demand for biological manufacturing is growing faster than capacity growth.
-
Bryn Partners With Aptar for Nasal Spray Device
11.01.19
Bryn’s Epinephrine Nasal Spray has two doses in one portable device.
